Inventor
CZERNIELEWSKI JANUSZ
FR15 patents
⚠️ This page may combine multiple inventors who share the name “CZERNIELEWSKI JANUSZ”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GALDERMA RES & DEV
10 patentsUS7579377B2Aug 25, 2009
Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
GALDERMA RES & DEV17 citations92
US9622994B2Apr 18, 2017
Method for the treatment of acne using pharmaceutical compositions comprising 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid
GALDERMA RES & DEV4 citations83
US9387187B2Jul 12, 2016
Administration of 6[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
GALDERMA RES & DEV3 citations83
US9381179B2Jul 5, 2016
Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
GALDERMA RES & DEV3 citations83
US7868044B2Jan 11, 2011
Method for the treatment of acne using compositions comprising 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid
GALDERMA RES & DEV2 citations73
US7838558B2Nov 23, 2010
Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
GALDERMA RES & DEV2 citations73
US7834060B2Nov 16, 2010
Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphtoic acid for the treatment of dermatological disorders
GALDERMA RES & DEV3 citations73
US7737181B2Jun 15, 2010
Pharmaceutical compositions comprising 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
GALDERMA RES & DEV3 citations73
US9901556B2Feb 27, 2018
Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
GALDERMA RES & DEV0 citations51
US9872842B2Jan 23, 2018
Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
GALDERMA RES & DEV0 citations51
GRAEBER MICHAEL
4 patentsUS8703820B2Apr 22, 2014
Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
GRAEBER MICHAEL7 citations92
US8729127B2May 20, 2014
Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
GRAEBER MICHAEL6 citations83
US8921423B2Dec 30, 2014
Method for the treatment of acne using compositions comprising 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid
GRAEBER MICHAEL1 citations62
US8653140B2Feb 18, 2014
Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
GRAEBER MICHAEL1 citations62